CU Chemie Uetikon GmbH

SEQENS is a global CDMO with 90+ years of experience in the custom development and manufacturing of APIs.

We partner with start-ups and emerging biotech companies to move their drug candidates from the earliest stages (pre-IND) to full-scale commercial production.

Our expertise covers the following modalities:

- Small molecules
- Short synthetic peptides (< 12 AA)
- Polymers
- Lipids
- Chelators

State-of-the-art R&D centers in Germany. France and the US, together with an integrated network of GMP manufacturing sites in Europe (Germany, France, Finland) and the US, make SEQENS the ideal partner from preclinical development to commercial supply.

Trusted by more than 1,000 customers worldwide, SEQENS combines the agility start-ups need with the robustness of an established industrial partner.